BioWorld MedTech

March 20, 2014

View Archived Issues

Washington Roundup: NHLBI eyes TGF-beta as culprit in failure of saphenous vein graft

Court Report: Biolitec CEO a no-show in court, must pay $74.9M to AngioDynamics

HIT Roundup: Health Level introduces software solution for cardiology centers

Financings roundup: Augmedix gets venture funds to expand technology team

Product briefs

People in Places

MDD's Orthopedic Extra

Move could help quell chaotic market: China prepares to crack down on host of device rule breakers

Chinese authorities are taking action to tackle illegal sales and marketing activities in the medical devices as they work to consolidate a market that remains chaotic. Read More

The MDD Interview: Esaote seeks growth by expanding portfolio, markets

Today's news in brief

BioWorld

BioWorld briefs for Nov. 25, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 25, 2024.

J&J’s Ottava robotic system approved for US pivotal trial

BioWorld MedTech

Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...